such as "Introduction", "Conclusion"..etc CHICAGO ---
Northwestern University Feinberg School of Medicine researchers
have found that an enzyme called ACE2 may hold the potential to
treat diabetic kidney disease, the most common form of kidney
disease. In the laboratory, researchers led by Daniel Batlle,
professor of medicine in the Feinberg School, chief of the
nephrology/hypertension division and staff nephrologist at
Northwestern Memorial Hospital, have found low levels of the
ACE2 enzyme in the glomeruli of the kidneys of diabetic mice.
When ACE2 was further decreased with an inhibitor drug, kidney
disease worsened. Studies are now needed using compounds that
increase the level of ACE2 in the kidneys of diabetic mice to
see if it reverses or prevents kidney disease from developing,
Batlle said. The experiments appear in a report by Ye et. al in
the November issue of the Journal of the American Society of
Nephrology. Diabetes, which affects 230 million people worldwide
and 21 million in the United States,